PSMA PET Utility for Determining Optimal Candidates for Focal Therapy

At the 2025 Urology On The Beach meeting, Rafael Sanchez-Salas, MD, of the Division of Urology at McGill University, comments on whether PSMA PET is useful and accurate in the patient diagnostic stage for determining optimal candidates for focal therapy.

He also shares his thoughts on whether PSMA PET alleviates the problem of over-biopsying and over-diagnosing patients with prostate cancer.

View his previous comments on Managing Localized Prostate Cancer: Criteria for Patient Selection for Focal Therapy.